Clinical Trials Browser

Phase 2 × Hematologic Diseases × Immunoglobulin G × Clear all

NCT04572815 2026-01-02

Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant

Phase 2 Active not recruiting

Hematologic Diseases